What If Adaptyv Bio Went On-Chain? Tokenizing Wet-Lab Compute for Autonomous AI Agents

By MDFWrites ·

How tokenized lab access and proof-of-experiment could let AI agents pay for and run real biology experiments — on-chain.

A quiet shift is already underway in protein engineering. Adaptyv Bio, a Swiss automated lab, has built what it calls a protein foundry: submit a sequence, and its robotics and microfluidics pipeline synthesizes and tests it, turning around clean experimental data in a matter of weeks instead of months. The company has gone a step further by opening an API that lets AI agents submit sequences, select assay types, get cost estimates, and pull back structured binding, expression, or thermostability data programmatically — no human in the loop required. That's the real infrastructure. Here's the thought experiment: what happens when the payment layer underneath that API becomes on-chain? From API Calls to Proof of Experiment Today, an AI agent using a service like Adaptyv's still settles payment the old way — an invoice, a credit line, a human-approved budget. But the underlying workflow is already agent-native: pick an assay, submit a design, get back a dataset. Swap the settlement layer for on-chain payment rails, and the same pipeline becomes something new — a market where autonomous agents pay for wet-lab compute the way they'd pay for GPU time. The missing piece is trust. Traditional lab results live in proprietary spreadsheets or paywalled PDFs, vulnerable to selective reporting and replication failure. Tokenizing wet-lab compute changes that: lab parameters, raw telemetry, and final assay outputs get anchored directly to a cryptographic hash. Every experimental run produces a proof of experiment — a record that's verifiable on-chain, not just claimed in a report. What This Unlocks This structural shift opens the door to: Immutable audit trails — Public, verifiable records of both experimental successes and failures, reducing the publication bias that keeps failed results hidden. Programmable IP — Validated assay results become on-chain data assets that can be composed, fractionalized, or licensed transparently, instead of sitting locked in a single company's…